A large fraction of HLA class I ligands are proteasome-generated spliced peptides
- PMID: 27846572
- DOI: 10.1126/science.aaf4384
A large fraction of HLA class I ligands are proteasome-generated spliced peptides
Abstract
The proteasome generates the epitopes presented on human leukocyte antigen (HLA) class I molecules that elicit CD8+ T cell responses. Reports of proteasome-generated spliced epitopes exist, but they have been regarded as rare events. Here, however, we show that the proteasome-generated spliced peptide pool accounts for one-third of the entire HLA class I immunopeptidome in terms of diversity and one-fourth in terms of abundance. This pool also represents a unique set of antigens, possessing particular and distinguishing features. We validated this observation using a range of complementary experimental and bioinformatics approaches, as well as multiple cell types. The widespread appearance and abundance of proteasome-catalyzed peptide splicing events has implications for immunobiology and autoimmunity theories and may provide a previously untapped source of epitopes for use in vaccines and cancer immunotherapy.
Copyright © 2016, American Association for the Advancement of Science.
Similar articles
-
Proteasome-Generated cis-Spliced Peptides and Their Potential Role in CD8+ T Cell Tolerance.Front Immunol. 2021 Feb 24;12:614276. doi: 10.3389/fimmu.2021.614276. eCollection 2021. Front Immunol. 2021. PMID: 33717099 Free PMC article.
-
Contribution of proteasome-catalyzed peptide cis-splicing to viral targeting by CD8+ T cells in HIV-1 infection.Proc Natl Acad Sci U S A. 2019 Dec 3;116(49):24748-24759. doi: 10.1073/pnas.1911622116. Epub 2019 Nov 20. Proc Natl Acad Sci U S A. 2019. PMID: 31748275 Free PMC article.
-
Post-Translational Peptide Splicing and T Cell Responses.Trends Immunol. 2017 Dec;38(12):904-915. doi: 10.1016/j.it.2017.07.011. Epub 2017 Aug 19. Trends Immunol. 2017. PMID: 28830734 Review.
-
CD8(+) T cells of Listeria monocytogenes-infected mice recognize both linear and spliced proteasome products.Eur J Immunol. 2016 May;46(5):1109-18. doi: 10.1002/eji.201545989. Epub 2016 Mar 16. Eur J Immunol. 2016. PMID: 26909514
-
Shuffling peptides to create T-cell epitopes: does the immune system play cards?Immunol Cell Biol. 2018 Jan;96(1):34-40. doi: 10.1111/imcb.1015. Epub 2017 Dec 7. Immunol Cell Biol. 2018. PMID: 29359347 Review.
Cited by
-
Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies.Hum Vaccin Immunother. 2024 Dec 31;20(1):2303799. doi: 10.1080/21645515.2024.2303799. Epub 2024 Feb 12. Hum Vaccin Immunother. 2024. PMID: 38346926 Free PMC article. Review.
-
Biological consequences of structural and functional proteasome diversity.Heliyon. 2018 Nov 2;4(10):e00894. doi: 10.1016/j.heliyon.2018.e00894. eCollection 2018 Oct. Heliyon. 2018. PMID: 30417153 Free PMC article. Review.
-
Digging deeper into the immunopeptidome: characterization of post-translationally modified peptides presented by MHC I.J Proteins Proteom. 2021;12(3):151-160. doi: 10.1007/s42485-021-00066-x. Epub 2021 Jun 4. J Proteins Proteom. 2021. PMID: 36619276 Free PMC article.
-
An unexplored angle: T cell antigen discoveries reveal a marginal contribution of proteasome splicing to the immunogenic MHC class I antigen pool.Proc Natl Acad Sci U S A. 2022 Jul 19;119(29):e2119736119. doi: 10.1073/pnas.2119736119. Epub 2022 Jul 8. Proc Natl Acad Sci U S A. 2022. PMID: 35858315 Free PMC article.
-
Neo-Splicetopes in Tumor Therapy: A Lost Case?Front Immunol. 2022 Feb 21;13:849863. doi: 10.3389/fimmu.2022.849863. eCollection 2022. Front Immunol. 2022. PMID: 35265089 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials